Enzyme
MLNDecentralized on-chain asset management protocol
Performances
RD Popularity Index
RD Growth Index
| 1h | 24h | 7d | 30d | 60d | 90d |
|---|---|---|---|---|---|
| 1.69% | 1.78% | 9.45% | 20.14% | 7.77% | 24.61% |
Revenue & Burn
Protocol income
$4.56KBuyback funds
--Burn funds
--Buyback ratio
--Protocol funds over time
Monthly amounts & ratios
| Period | Protocol income | Buyback funds | Burn funds | Buyback ratio |
|---|---|---|---|---|
| Nov 2026 | $4.56K | -- | -- | -- |
| Oct 2026 | $5.9K | -- | -- | -- |
| Sep 2026 | $27.73K | -- | -- | -- |
| Aug 2026 | $8.59K | -- | -- | -- |
| Jul 2026 | $8.54K | -- | -- | -- |
| Jun 2026 | $6.39K | -- | -- | -- |
Comparison
Fundraising
Top Holders
| Address | Token | Quantity | Percentage | Value |
|---|---|---|---|---|
| 0xa6a6...fd37 | ![]() MLN | 372,598.26 | 11.38% | $428.48K |
| Coinbase 10 (3e43) | ![]() MLN | 276,206.75 | 8.43% | $317.63K |
| 0x15da...b0d7 | ![]() MLN | 248,252.85 | 7.58% | $285.49K |
Open Markets
| # | Exchange | Pair | Price | +2% depth | -2% depth | Volume (24h) | volume % |
|---|---|---|---|---|---|---|---|
| 1 | HHTXCEX | MLN/USDT | $5.06 | $11 | $187 | $1,907,382 | 4493.20% |
| 2 | MLN/USD | $4.56 | $22,247 | $42,627 | $95,101 | 224.03% | |
| 3 | BBingXCEX | MLN/USDT | $4.57 | $22,835 | $34,495 | $76,293 | 179.72% |
| 4 | KKrakenCEX | MLN/USD | $4.57 | $10,556 | $11,683 | $33,511 | 78.94% |
| 5 | KKrakenCEX | MLN/EUR | $4.55 | $4,464 | $3,774 | $16,731 | 39.41% |
| 6 | PPhemexCEX | MLN/USDT | $4.57 | $631 | $801 | $9,464 | 22.30% |
| 7 | MLN/USD | $4.56 | $1,944 | $1,955 | $3,582 | 8.44% | |
| 8 | MLN/WETH | $4.59 | $3,407 | $3,397 | $2,591 | 6.10% | |
| 9 | DAI/MLN | $16.16 | $68 | $67 | $196 | 0.46% | |
| 10 | KKrakenCEX | MLN/XBT | $4.58 | $899 | $3,367 | $48 | 0.11% |
Follow Updates
Follow Lists
People
About Enzyme
Enzyme is an on-chain asset management protocol started in 2016, formerly Melon and governed by the Enzyme Council DAO since 2019. It packages funds into smart-contract vaults: managers allocate assets and execute strategies inside a vault, collecting management and performance fees, while fund participants hold claims to net asset value and redemption rights, with profit sharing, fees and risk parameters such as token whitelists, leverage caps and slippage thresholds enforced automatically by contracts without any custodian.
After the 2023 v4 upgrade (codenamed Sulu), vaults split into Public, Private and Hybrid types for different compliance needs, and the product line bifurcated into Blue, a hosted interface covering Ethereum, Arbitrum, Polygon, Base and over 30 protocols, and Onyx, a wallet-as-tokenization layer unrestricted by chain or protocol; in 2025 Enzyme partnered with CV5 Capital to provide issuance and administration infrastructure for tokenized funds under a Cayman framework.
Mona El Isa, co-founder and CEO of Enzyme.
Previously worked at Goldman Sachs as Vice President of Equities Trading. Founded Melon Protocol (later renamed Enzyme) in 2016, focusing on decentralized asset management. She is also the founder and CEO of Avantgarde Finance.
Enzyme charges a 50 bps protocol fee on Assets Under Technology, reduced to 25 bps when the fee is paid in MLN.
Enzyme accrues the protocol fee on each vault deposit, share redemption or migration, settling at 25 bps for vaults that use share buybacks and 50 bps for those that do not.

